AddLife AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
July 15, 2024 at 06:45 am
Share
AddLife AB (publ) reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was SEK 2,554 million compared to SEK 2,365 million a year ago. Net income was SEK 72 million compared to SEK 32 million a year ago. Basic earnings per share from continuing operations was SEK 0.6 compared to SEK 0.27 a year ago. Diluted earnings per share from continuing operations was SEK 0.6 compared to SEK 0.27 a year ago.
For the six months, sales was SEK 5,124 million compared to SEK 4,822 million a year ago. Net income was SEK 134 million compared to SEK 206 million a year ago. Basic earnings per share from continuing operations was SEK 1.11 compared to SEK 1.7 a year ago. Diluted earnings per share from continuing operations was SEK 1.11 compared to SEK 1.7 a year ago.
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
ADDLIFE AB 
